Ivermectin for preventing and treating COVID-19-Reference-Cited by-同舟云学术

Ivermectin for preventing and treating COVID-19

Published:2021-07-28 Issue:10 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Popp Maria¹,Stegemann Miriam²,Metzendorf Maria-Inti²,Gould Susan³,Kranke Peter⁴,Meybohm Patrick¹,Skoetz Nicole⁵,Weibel Stephanie¹

Affiliation:

1. Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine; University Hospital Wuerzburg; Wuerzburg Germany

2. Germany

3. Royal Liverpool University Hospital; Liverpool UK

4. Department of Anaesthesia and Critical Care; University of Würzburg; Würzburg Germany

5. Faculty of Medicine and University Hospital Cologne, Department of Internal Medicine; Center for Integrated Oncology, University of Cologne; Cologne Germany

Publisher

Wiley

Subject

Pharmacology (medical)

Reference212 articles.

1. A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness;Ahmed;International Journal of Infectious Diseases,2020

2. Chaccour C Casellas A Blanco-Di Matteo A Pineda I Fernandez-Montero A Ruiz-Castillo P The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with mild COVID-19: a pilot, double-blind, placebo-controlled, randomized clinical trial researchsquare.com/article/rs-116547/v1 10.21203/rs.3.rs-116547/v1

3. The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: a pilot, double-blind, placebo-controlled, randomized clinical trial;Chaccour;EClinicalMedicine,2021

4. The SARS-CoV-2 ivermectin Navarra-ISGlobal Trial (SAINT) to evaluate the potential of ivermectin to reduce COVID-19 transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: a structured summary of a study protocol for a randomized control pilot trial;Chaccour;Trials,2020

5. Pilot study to evaluate the potential of ivermectin to reduce COVID-19 transmission www.clinicaltrialsregister.eu/ctr-search/trial/2020-001474-29/ES

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of ivermectin and factors associated with the prevention and/or treatment of COVID-19: a cross-sectional online survey in the province of Chincha, Peru;F1000Research;2024-01-08

2. Erythromycin, retapamulin, pyridoxine, folic acid, and ivermectin inhibit cytopathic effect, papain-like protease, and MPRO enzymes of SARS-CoV-2;Frontiers in Cellular and Infection Microbiology;2023-11-27

3. Ivermectin as a potential therapeutic strategy for glioma;Journal of Neuroscience Research;2023-10-10

4. The effect of intravenous lipid emulsion (ILE) on the pharmacokinetic/toxicokinetic dispositions of ivermectin and carprofen in rabbits;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-09-28

5. Use of ivermectin and factors associated with the prevention and/or treatment of COVID-19: a cross-sectional online survey in the province of Chincha, Peru;F1000Research;2023-08-29